EV carrying transmembrane glycoproteins present on the surface of cancer cells may stimulate other cells to produce proteins that break down the basal membrane of healthy cells, and EV carrying TRPC5 induces resistance to anthracycline in other cancer cells [39]. This evidence concerns the gene TRPC5 and cancer.